A Prospective Analysis of the Cephalic Vein Cutdown Approach for Chronic Indwelling Central Venous Access in 100 Consecutive Cancer Patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-08

AUTHORS

Stephen P. Povoski

ABSTRACT

BACKGROUND: Chronic indwelling central venous access devices (CICVAD) generally are placed by the percutaneous subclavian vein approach. The cephalic vein cutdown approach is used only infrequently. Although the technique has been well described, few prospective data are available on the cephalic vein cutdown approach. METHODS: From September 9, 1998, to July 20, 1999, the cephalic vein cutdown approach was attempted in 100 consecutive cancer patients taken to the operating room with the intention of placing CICVAD. Median patient age was 54.5 years (range 18-88), with 46 men and 54 women. Twenty-five patients had gastrointestinal malignancies, 17 had breast cancer, 15 had lymphoma, 13 had lung cancer, 12 had leukemia, 5 had multiple myeloma, and 13 had other malignancies. Patients were followed prospectively for immediate and long-term outcome. RESULTS: CICVAD placement via the cephalic vein cutdown approach was successful in 82 patients; the remaining 18 patients required conversion to a percutaneous subclavian vein approach. The reasons for inability to place CICVAD via cephalic vein cutdown approach were a cephalic vein that was too small (10 patients), an absent cephalic vein (7 patients), and inability to traverse the angle of insertion of the cephalic vein into the subclavian vein (1 patient). There were 56 subcutaneous ports and 26 tunneled catheters. Median operating time was 44 minutes (range, 26-79 minutes). No postoperative pneumothorax occurred. Median catheter duration was 198 days (range, 0-513 days). Long-term complications included catheter-related bacteremia (6%), site infection (2%), deep venous thrombosis (5%), port pocket hematoma (1%), and superior vena cava stricture (1%). Thirty-seven percent of patients have died since CICVAD placement. Twenty-nine percent of the CICVADs have been removed. CONCLUSIONS: The cephalic vein cutdown approach was successful in 82% of patients. This approach is a safe and useful alternative to the percutaneous subclavian vein approach. More... »

PAGES

496-502

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10434-000-0496-9

DOI

http://dx.doi.org/10.1007/s10434-000-0496-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038959860

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10947017


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Catheterization, Central Venous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Catheters, Indwelling", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Subclavian Vein", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "West Virginia University", 
          "id": "https://www.grid.ac/institutes/grid.268154.c", 
          "name": [
            "Section of Surgical Oncology, Department of Surgery, West Virginia University, Robert C. Byrd Health Science Center, and Mary Babb Randolph Cancer Center, 26506, Morgantown, West Virginia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Povoski", 
        "givenName": "Stephen P.", 
        "id": "sg:person.01240351036.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240351036.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1001/jama.1982.03330210050034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005290231"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0011-3840(96)80008-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007850363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(97)89012-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008649943"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(97)89012-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008649943"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1981.03320020032019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023857224"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0748-7983(97)93205-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026570949"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0196-6553(95)90041-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039419030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00043426-199122000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060298593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00043426-199122000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060298593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00043426-199122000-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060298593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-119-12-199312150-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073697543"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074699781", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078327478", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079384173", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079567948", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079595472", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079693215", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079724534", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081784920", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081993972", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082652716", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082685998", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082709939", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082777804", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083223579", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2000-08", 
    "datePublishedReg": "2000-08-01", 
    "description": "BACKGROUND: Chronic indwelling central venous access devices (CICVAD) generally are placed by the percutaneous subclavian vein approach. The cephalic vein cutdown approach is used only infrequently. Although the technique has been well described, few prospective data are available on the cephalic vein cutdown approach.\nMETHODS: From September 9, 1998, to July 20, 1999, the cephalic vein cutdown approach was attempted in 100 consecutive cancer patients taken to the operating room with the intention of placing CICVAD. Median patient age was 54.5 years (range 18-88), with 46 men and 54 women. Twenty-five patients had gastrointestinal malignancies, 17 had breast cancer, 15 had lymphoma, 13 had lung cancer, 12 had leukemia, 5 had multiple myeloma, and 13 had other malignancies. Patients were followed prospectively for immediate and long-term outcome.\nRESULTS: CICVAD placement via the cephalic vein cutdown approach was successful in 82 patients; the remaining 18 patients required conversion to a percutaneous subclavian vein approach. The reasons for inability to place CICVAD via cephalic vein cutdown approach were a cephalic vein that was too small (10 patients), an absent cephalic vein (7 patients), and inability to traverse the angle of insertion of the cephalic vein into the subclavian vein (1 patient). There were 56 subcutaneous ports and 26 tunneled catheters. Median operating time was 44 minutes (range, 26-79 minutes). No postoperative pneumothorax occurred. Median catheter duration was 198 days (range, 0-513 days). Long-term complications included catheter-related bacteremia (6%), site infection (2%), deep venous thrombosis (5%), port pocket hematoma (1%), and superior vena cava stricture (1%). Thirty-seven percent of patients have died since CICVAD placement. Twenty-nine percent of the CICVADs have been removed.\nCONCLUSIONS: The cephalic vein cutdown approach was successful in 82% of patients. This approach is a safe and useful alternative to the percutaneous subclavian vein approach.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10434-000-0496-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1105545", 
        "issn": [
          "1068-9265", 
          "1534-4681"
        ], 
        "name": "Annals of Surgical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "name": "A Prospective Analysis of the Cephalic Vein Cutdown Approach for Chronic Indwelling Central Venous Access in 100 Consecutive Cancer Patients", 
    "pagination": "496-502", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b9959688a88b29181c2d110d27b4b7d40923259fb1b6ed9a69bb25b724054c1d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10947017"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9420840"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10434-000-0496-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038959860"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10434-000-0496-9", 
      "https://app.dimensions.ai/details/publication/pub.1038959860"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T13:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8659_00000482.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s10434-000-0496-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10434-000-0496-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10434-000-0496-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10434-000-0496-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10434-000-0496-9'


 

This table displays all metadata directly associated to this object as RDF triples.

177 TRIPLES      21 PREDICATES      65 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10434-000-0496-9 schema:about N07b14bbf8ae940c299b843b78422fb52
2 N11b3138f353b473aa70f356421d6e1b7
3 N1621279c9ab44211adf01fd113dd1113
4 N16bfa2b1e35744138b3bf0bed50e0142
5 N2c318452e07448bf98435e97a34bbbdb
6 N2c9ac2c21e5341aea5d564cd1241575d
7 N36af80559bd24e94aae4fd9a5833984d
8 N3e0e5f9a79a84f0989b0776ae4bfb559
9 N425414a7bca84a81a43c2374bf5e4090
10 N4cd2ab857c2849cb8f918ead4d70c2ba
11 N8463c1c24c1040999757c8492da677dd
12 N956e11f27fb64415b8eb4d83c78dbcb2
13 Nc26fdc7d43e042318e743a70e24929c9
14 Nd93bdb876daa4699ac6cb1153ecf1ce8
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author Nc80dfd1591c14d009d2014d7d4d37628
18 schema:citation https://app.dimensions.ai/details/publication/pub.1074699781
19 https://app.dimensions.ai/details/publication/pub.1078327478
20 https://app.dimensions.ai/details/publication/pub.1079384173
21 https://app.dimensions.ai/details/publication/pub.1079567948
22 https://app.dimensions.ai/details/publication/pub.1079595472
23 https://app.dimensions.ai/details/publication/pub.1079693215
24 https://app.dimensions.ai/details/publication/pub.1079724534
25 https://app.dimensions.ai/details/publication/pub.1081784920
26 https://app.dimensions.ai/details/publication/pub.1081993972
27 https://app.dimensions.ai/details/publication/pub.1082652716
28 https://app.dimensions.ai/details/publication/pub.1082685998
29 https://app.dimensions.ai/details/publication/pub.1082709939
30 https://app.dimensions.ai/details/publication/pub.1082777804
31 https://app.dimensions.ai/details/publication/pub.1083223579
32 https://doi.org/10.1001/jama.1981.03320020032019
33 https://doi.org/10.1001/jama.1982.03330210050034
34 https://doi.org/10.1016/0196-6553(95)90041-1
35 https://doi.org/10.1016/s0011-3840(96)80008-6
36 https://doi.org/10.1016/s0748-7983(97)93205-4
37 https://doi.org/10.1016/s0959-8049(97)89012-0
38 https://doi.org/10.1097/00043426-199122000-00003
39 https://doi.org/10.7326/0003-4819-119-12-199312150-00003
40 schema:datePublished 2000-08
41 schema:datePublishedReg 2000-08-01
42 schema:description BACKGROUND: Chronic indwelling central venous access devices (CICVAD) generally are placed by the percutaneous subclavian vein approach. The cephalic vein cutdown approach is used only infrequently. Although the technique has been well described, few prospective data are available on the cephalic vein cutdown approach. METHODS: From September 9, 1998, to July 20, 1999, the cephalic vein cutdown approach was attempted in 100 consecutive cancer patients taken to the operating room with the intention of placing CICVAD. Median patient age was 54.5 years (range 18-88), with 46 men and 54 women. Twenty-five patients had gastrointestinal malignancies, 17 had breast cancer, 15 had lymphoma, 13 had lung cancer, 12 had leukemia, 5 had multiple myeloma, and 13 had other malignancies. Patients were followed prospectively for immediate and long-term outcome. RESULTS: CICVAD placement via the cephalic vein cutdown approach was successful in 82 patients; the remaining 18 patients required conversion to a percutaneous subclavian vein approach. The reasons for inability to place CICVAD via cephalic vein cutdown approach were a cephalic vein that was too small (10 patients), an absent cephalic vein (7 patients), and inability to traverse the angle of insertion of the cephalic vein into the subclavian vein (1 patient). There were 56 subcutaneous ports and 26 tunneled catheters. Median operating time was 44 minutes (range, 26-79 minutes). No postoperative pneumothorax occurred. Median catheter duration was 198 days (range, 0-513 days). Long-term complications included catheter-related bacteremia (6%), site infection (2%), deep venous thrombosis (5%), port pocket hematoma (1%), and superior vena cava stricture (1%). Thirty-seven percent of patients have died since CICVAD placement. Twenty-nine percent of the CICVADs have been removed. CONCLUSIONS: The cephalic vein cutdown approach was successful in 82% of patients. This approach is a safe and useful alternative to the percutaneous subclavian vein approach.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree false
46 schema:isPartOf N495fd33dcad744ffb0fe9afd56286bf1
47 Ne4743a076d75412f816e2da272f1ce3c
48 sg:journal.1105545
49 schema:name A Prospective Analysis of the Cephalic Vein Cutdown Approach for Chronic Indwelling Central Venous Access in 100 Consecutive Cancer Patients
50 schema:pagination 496-502
51 schema:productId N19a145c9a2e8482fa55996891404bfd1
52 N1be83f2f84c0497f92f85822eb62e783
53 N212156b0c6c84b70962f969cb4f5aa20
54 N582b988af246407eb6a38050954f5fba
55 N9f0790f6e2374fc7af2fd2c0d93c6d5a
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038959860
57 https://doi.org/10.1007/s10434-000-0496-9
58 schema:sdDatePublished 2019-04-10T13:05
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher N067eb9e9b9b24ea186ce08ba7ea35d66
61 schema:url http://link.springer.com/10.1007/s10434-000-0496-9
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N067eb9e9b9b24ea186ce08ba7ea35d66 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N07b14bbf8ae940c299b843b78422fb52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Adult
69 rdf:type schema:DefinedTerm
70 N11b3138f353b473aa70f356421d6e1b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Subclavian Vein
72 rdf:type schema:DefinedTerm
73 N1621279c9ab44211adf01fd113dd1113 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Neoplasms
75 rdf:type schema:DefinedTerm
76 N16bfa2b1e35744138b3bf0bed50e0142 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Humans
78 rdf:type schema:DefinedTerm
79 N19a145c9a2e8482fa55996891404bfd1 schema:name nlm_unique_id
80 schema:value 9420840
81 rdf:type schema:PropertyValue
82 N1be83f2f84c0497f92f85822eb62e783 schema:name readcube_id
83 schema:value b9959688a88b29181c2d110d27b4b7d40923259fb1b6ed9a69bb25b724054c1d
84 rdf:type schema:PropertyValue
85 N212156b0c6c84b70962f969cb4f5aa20 schema:name doi
86 schema:value 10.1007/s10434-000-0496-9
87 rdf:type schema:PropertyValue
88 N2c318452e07448bf98435e97a34bbbdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Aged, 80 and over
90 rdf:type schema:DefinedTerm
91 N2c9ac2c21e5341aea5d564cd1241575d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Female
93 rdf:type schema:DefinedTerm
94 N36af80559bd24e94aae4fd9a5833984d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Adolescent
96 rdf:type schema:DefinedTerm
97 N3e0e5f9a79a84f0989b0776ae4bfb559 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Catheters, Indwelling
99 rdf:type schema:DefinedTerm
100 N425414a7bca84a81a43c2374bf5e4090 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Catheterization, Central Venous
102 rdf:type schema:DefinedTerm
103 N495fd33dcad744ffb0fe9afd56286bf1 schema:issueNumber 7
104 rdf:type schema:PublicationIssue
105 N4cd2ab857c2849cb8f918ead4d70c2ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Antineoplastic Agents
107 rdf:type schema:DefinedTerm
108 N582b988af246407eb6a38050954f5fba schema:name pubmed_id
109 schema:value 10947017
110 rdf:type schema:PropertyValue
111 N8463c1c24c1040999757c8492da677dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Aged
113 rdf:type schema:DefinedTerm
114 N956e11f27fb64415b8eb4d83c78dbcb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Middle Aged
116 rdf:type schema:DefinedTerm
117 N9f0790f6e2374fc7af2fd2c0d93c6d5a schema:name dimensions_id
118 schema:value pub.1038959860
119 rdf:type schema:PropertyValue
120 Nc26fdc7d43e042318e743a70e24929c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Prospective Studies
122 rdf:type schema:DefinedTerm
123 Nc80dfd1591c14d009d2014d7d4d37628 rdf:first sg:person.01240351036.37
124 rdf:rest rdf:nil
125 Nd93bdb876daa4699ac6cb1153ecf1ce8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Male
127 rdf:type schema:DefinedTerm
128 Ne4743a076d75412f816e2da272f1ce3c schema:volumeNumber 7
129 rdf:type schema:PublicationVolume
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
134 schema:name Oncology and Carcinogenesis
135 rdf:type schema:DefinedTerm
136 sg:journal.1105545 schema:issn 1068-9265
137 1534-4681
138 schema:name Annals of Surgical Oncology
139 rdf:type schema:Periodical
140 sg:person.01240351036.37 schema:affiliation https://www.grid.ac/institutes/grid.268154.c
141 schema:familyName Povoski
142 schema:givenName Stephen P.
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240351036.37
144 rdf:type schema:Person
145 https://app.dimensions.ai/details/publication/pub.1074699781 schema:CreativeWork
146 https://app.dimensions.ai/details/publication/pub.1078327478 schema:CreativeWork
147 https://app.dimensions.ai/details/publication/pub.1079384173 schema:CreativeWork
148 https://app.dimensions.ai/details/publication/pub.1079567948 schema:CreativeWork
149 https://app.dimensions.ai/details/publication/pub.1079595472 schema:CreativeWork
150 https://app.dimensions.ai/details/publication/pub.1079693215 schema:CreativeWork
151 https://app.dimensions.ai/details/publication/pub.1079724534 schema:CreativeWork
152 https://app.dimensions.ai/details/publication/pub.1081784920 schema:CreativeWork
153 https://app.dimensions.ai/details/publication/pub.1081993972 schema:CreativeWork
154 https://app.dimensions.ai/details/publication/pub.1082652716 schema:CreativeWork
155 https://app.dimensions.ai/details/publication/pub.1082685998 schema:CreativeWork
156 https://app.dimensions.ai/details/publication/pub.1082709939 schema:CreativeWork
157 https://app.dimensions.ai/details/publication/pub.1082777804 schema:CreativeWork
158 https://app.dimensions.ai/details/publication/pub.1083223579 schema:CreativeWork
159 https://doi.org/10.1001/jama.1981.03320020032019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023857224
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1001/jama.1982.03330210050034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005290231
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1016/0196-6553(95)90041-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039419030
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1016/s0011-3840(96)80008-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007850363
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1016/s0748-7983(97)93205-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026570949
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1016/s0959-8049(97)89012-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008649943
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1097/00043426-199122000-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060298593
172 rdf:type schema:CreativeWork
173 https://doi.org/10.7326/0003-4819-119-12-199312150-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073697543
174 rdf:type schema:CreativeWork
175 https://www.grid.ac/institutes/grid.268154.c schema:alternateName West Virginia University
176 schema:name Section of Surgical Oncology, Department of Surgery, West Virginia University, Robert C. Byrd Health Science Center, and Mary Babb Randolph Cancer Center, 26506, Morgantown, West Virginia
177 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...